Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0001209191-15-051909

Options or other derivatives

  • Director acquired 6,083 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bronstein Ben Director 2015-06-09 Grant or award · Employee Stock Option (Right to Buy) +6,083 6,083 D
Loading xslF345X03/doc4.xml…